Read the full article on The Market Herald here.
- Medicinal cannabis company Little Green Pharma (LGP) has updated the market on its financial and operational activities over 2020's final quarterIn terms of finances, LGP's quarterly sales revenue hit $2.45 million, marking a 90 per cent upswing on the previous quarter
- All up, cash receipts for the period came in at $1.86 million, taking LGP's cash position for the quarter to just shy of $4.5 million
- The ASX-lister also continued its international market pursuits, completing its fist export to Germany and receiving a primary supplier role for a national French medicinal cannabis trial
Medicinal cannabis company Little Green Pharma (LGP) has updated...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
-0.008(6.67%) |
Mkt cap ! $32.00M | |||
| Open | High | Low | Value | Volume |
| 11.3¢ | 11.3¢ | 10.5¢ | $64.64K | 595.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 608596 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 166618 | 4 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| LGP (ASX) Chart |